C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/113 (2010.01) A61K 31/7088 (2006.01) A61K 31/713 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) C07K 16/18 (2006.01) C07K 16/22 (2006.01) A61K 9/127 (2006.01) A61K 47/24 (2006.01) C07K 14/475 (2006.01)
Patent
CA 2717736
The present invention relates to nucleic acids and antibodies against SRPX2 and SRPX2 protein function in angio-genesis. Angiogenesis-related conditions, such as cancer or wound healing, can be treated by the composition comprising the SR- PX2 antagonists or agonists, respectively.
La présente invention concerne des acides nucléiques et des anticorps contre la SRPX2 et la fonction protéine SRPX2 dans l'angiogenèse. Des affections liées à l'angiogenèse, comme le cancer ou la guérison de plaies, peuvent être traitées par la composition qui comprend des antagonistes ou des agonistes de SRPX2, respectivement.
Hammel Philippe
Imhof Beat A.
Miljkovic-Licina Marijana
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Research Development Foundation
LandOfFree
Modulation of srpx2-mediated angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of srpx2-mediated angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of srpx2-mediated angiogenesis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1427387